The Trump administration has slashed $766 million allocated in funding to Moderna Inc., an American biotech and ...

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

Moderna (NASDAQ:MRNA) shares traded flat in the premarket on Thursday despite a decision by the U.S. Department of Health and Human Services (HHS) to terminate a contract worth $766M awarded to the ...

US President Donald Trump's administration on Wednesday canceled a $590 million contract with Moderna to develop an avian flu ...

The Trump administration terminated a nearly $600 million award to Moderna for developing an mRNA-based bird flu vaccine, ...

But on Wednesday, May 28 Moderna revealed the HHS has terminated the award for late-stage development and right to purchase ...

The Trump administration has cancelled a contract awarded to Moderna for the late-stage development of its bird flu vaccine ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

Moderna announced positive interim results from an early-stage trial of a vaccine that targeted bird flu virus.

The Trump administration on Wednesday canceled a $766 million contract with Moderna that funded efforts to develop a vaccine ...

H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award ...